1. Home
  2. AGCO vs NUVL Comparison

AGCO vs NUVL Comparison

Compare AGCO & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGCO
  • NUVL
  • Stock Information
  • Founded
  • AGCO 1990
  • NUVL 2017
  • Country
  • AGCO United States
  • NUVL United States
  • Employees
  • AGCO N/A
  • NUVL N/A
  • Industry
  • AGCO Industrial Machinery/Components
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGCO Industrials
  • NUVL Health Care
  • Exchange
  • AGCO Nasdaq
  • NUVL Nasdaq
  • Market Cap
  • AGCO 7.9B
  • NUVL 5.6B
  • IPO Year
  • AGCO 1992
  • NUVL 2021
  • Fundamental
  • Price
  • AGCO $97.96
  • NUVL $74.61
  • Analyst Decision
  • AGCO Hold
  • NUVL Strong Buy
  • Analyst Count
  • AGCO 11
  • NUVL 8
  • Target Price
  • AGCO $102.30
  • NUVL $115.50
  • AVG Volume (30 Days)
  • AGCO 822.8K
  • NUVL 548.5K
  • Earning Date
  • AGCO 07-29-2025
  • NUVL 05-08-2025
  • Dividend Yield
  • AGCO 1.18%
  • NUVL N/A
  • EPS Growth
  • AGCO N/A
  • NUVL N/A
  • EPS
  • AGCO N/A
  • NUVL N/A
  • Revenue
  • AGCO $10,783,700,000.00
  • NUVL N/A
  • Revenue This Year
  • AGCO N/A
  • NUVL N/A
  • Revenue Next Year
  • AGCO $5.57
  • NUVL N/A
  • P/E Ratio
  • AGCO N/A
  • NUVL N/A
  • Revenue Growth
  • AGCO N/A
  • NUVL N/A
  • 52 Week Low
  • AGCO $73.79
  • NUVL $55.54
  • 52 Week High
  • AGCO $108.76
  • NUVL $113.51
  • Technical
  • Relative Strength Index (RSI)
  • AGCO 48.98
  • NUVL 54.31
  • Support Level
  • AGCO $99.38
  • NUVL $70.25
  • Resistance Level
  • AGCO $103.13
  • NUVL $75.97
  • Average True Range (ATR)
  • AGCO 2.29
  • NUVL 3.09
  • MACD
  • AGCO -0.92
  • NUVL 0.13
  • Stochastic Oscillator
  • AGCO 2.00
  • NUVL 79.92

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: